New Fellow Bootcamp Series: Metastatic Cancer of “Origin TBD”

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. 

Next up: Metastatic Cancer of “Origin TBD,” a common question that comes up on solid oncology consults! [Originally episode 008]


Be sure to check out our Rotation Guides to get you in tip-top shape for fellowship!


Not to be confused with “carcinoma of unknown primary,” in this episode of metastatic disease of “origin TBD”, we discuss the workup of a mass noted incidentally on imaging.
This is a very high yield topic often faced on solid oncology consults!

Major Points Covered:

  • Mass found incidentally on imaging → we need to stage always

  • Initial Workup:

    • Reasonable to get CBC, CMP, UA, PSA (if male)

      • Low blood counts, maybe marrow involvement

      • Cr elevated concern for obstruction possibly

      • LFTs elevated concern for mass in the biliary/pancreas region

      • UA w/ hematuria → maybe bladder

      • But bottom line you’re gonna get a scan, which scan to get though?

    • Recommend referencing NCCN guidelines to determine additional staging scans

      • Create an account on nccn.org and look at guidelines by tumor type

      • Not all cancers require a PET/CT scan

      • There are newer modalities for imaging other than FDG PET including PSMA PET (prostate), Auxumin PET (prostate), and DOTATE PET (neuroendocrine)

      • Certain cancers can be diagnosed on imaging alone (RCC and HCC)

      • Some cancers require Brain MRI for staging

  • What to biopsy?

    • FNA often adequate for solid tumors but may need core if non diagnostic

    • Need core or ideally excisional if highly concerned for lymphoma

    • Always try to biopsy the site that will upstage

      • Distant lymph nodes or other metastatic sites

  • What about tumor markers?

    • We use this for treatment monitoring, not for diagnostic purposes

    • Important to establish a baseline to follow, special circumstances for diagnostic purposes to consider below:

      • PSA in male if concerned about prostate cancer

      • AFP helpful if concerned for HCC → liver masses in a cirrhotic

      • AFP and b-HCG if concerned for testicular → young or middle aged male with mediastinal mass

  • Molecular testing not necessarily needed at the time of biopsy 


Previous
Previous

New Fellow Bootcamp Series: SVC Syndrome

Next
Next

New Fellow Bootcamp Series: ITP